| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 374,556 | 377,749 | 336,261 | 348,375 | | Cost of Revenue | 217,236 | 217,622 | 189,132 | 200,794 | | | Gross Profit | 157,320 | 160,127 | 147,129 | 147,581 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 131,024 | 129,449 | 125,988 | 134,428 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 26,296 | 30,678 | 21,141 | 13,153 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 26,296 | 30,678 | 21,141 | 12,487 | | Interest Expense | 8,866 | 9,935 | 9,258 | 9,812 | | Income Before Tax | 17,430 | 20,743 | 11,883 | 2,675 | | Income Tax Expense | 1,043 | 7,825 | 3,060 | 1,259 | | Minority Interest | (1,982) |
-
|
-
| (666) | | | | Net Income From Continuing Ops | 14,405 | 12,918 | 8,823 | 1,416 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,405 | 12,918 | 8,823 | 1,416 | | Preferred Stock And Other Adjustments | 1,023 | (731) | (292) |
-
| | | Net Income Applicable To Common Shares | $15,428 | $12,187 | $8,531 | $1,416 |
|
1.52% Nasdaq 0.00%
Income Statement
